Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett G Hollier

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Mammary Gland Biology and Neoplasia|February 27, 2009
The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapiesBrett G Hollier, Kurt Evans, Sendurai A Mani
Cell Adhesion & Migration|April 10, 2014
Poly(2-oxazoline) hydrogels as next generation three-dimensional cell supportsTim R Dargaville, Brett G Hollier, Ali Shokoohmand, et al.
Trends in Molecular Medicine|September 29, 2014
Epithelial plasticity in prostate cancer: principles and clinical perspectivesRajdeep Das, Philip A Gregory, Brett G Hollier, et al.
Growth Factors (Chur, Switzerland)|February 1, 2008
Chimeric vitronectin:insulin-like growth factor proteins enhance cell growth and migration through co-activation of receptorsDerek R Van Lonkhuyzen, Brett G Hollier, Gary K Shooter, et al.
Endocrinology|December 15, 2007
Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptorBrett G Hollier, Jennifer A Kricker, Derek R Van Lonkhuyzen, et al.
Frontiers in Oncology|January 8, 2015
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for interventionMannan Nouri, Ellca Ratther, Nataly Stylianou, et al.
Endocrinology|February 10, 2011
Insulin-like growth factor-I:vitronectin complex-induced changes in gene expression effect breast cell survival and migrationAbhishek S Kashyap, Brett G Hollier, Kerry J Manton, et al.
IUBMB Life|September 14, 2013
Vitronectin--master controller or micromanager?David I Leavesley, Abhishek S Kashyap, Tristan Croll, et al.
International Journal of Pharmaceutics|September 17, 2017
Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumoursJames C Evans, Meenakshi Malhotra, Katrina Sweeney, et al.
Scientific Reports|January 14, 2018
Targeting Insulin-Like Growth Factor-I and Extracellular Matrix Interactions in Melanoma ProgressionBerline Murekatete, Ali Shokoohmand, Jacqui McGovern, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Mammary Gland Biology and Neoplasia|February 27, 2009
The epithelial-to-mesenchymal transition and cancer stem cells: a coalition against cancer therapiesBrett G Hollier, Kurt Evans, Sendurai A Mani
Cell Adhesion & Migration|April 10, 2014
Poly(2-oxazoline) hydrogels as next generation three-dimensional cell supportsTim R Dargaville, Brett G Hollier, Ali Shokoohmand, et al.
Trends in Molecular Medicine|September 29, 2014
Epithelial plasticity in prostate cancer: principles and clinical perspectivesRajdeep Das, Philip A Gregory, Brett G Hollier, et al.
Growth Factors (Chur, Switzerland)|February 1, 2008
Chimeric vitronectin:insulin-like growth factor proteins enhance cell growth and migration through co-activation of receptorsDerek R Van Lonkhuyzen, Brett G Hollier, Gary K Shooter, et al.
Endocrinology|December 15, 2007
Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptorBrett G Hollier, Jennifer A Kricker, Derek R Van Lonkhuyzen, et al.
Frontiers in Oncology|January 8, 2015
Androgen-targeted therapy-induced epithelial mesenchymal plasticity and neuroendocrine transdifferentiation in prostate cancer: an opportunity for interventionMannan Nouri, Ellca Ratther, Nataly Stylianou, et al.
Endocrinology|February 10, 2011
Insulin-like growth factor-I:vitronectin complex-induced changes in gene expression effect breast cell survival and migrationAbhishek S Kashyap, Brett G Hollier, Kerry J Manton, et al.
IUBMB Life|September 14, 2013
Vitronectin--master controller or micromanager?David I Leavesley, Abhishek S Kashyap, Tristan Croll, et al.
International Journal of Pharmaceutics|September 17, 2017
Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumoursJames C Evans, Meenakshi Malhotra, Katrina Sweeney, et al.
Scientific Reports|January 14, 2018
Targeting Insulin-Like Growth Factor-I and Extracellular Matrix Interactions in Melanoma ProgressionBerline Murekatete, Ali Shokoohmand, Jacqui McGovern, et al.
Pageof 4